Tag Archive for: cell therapy

A company executive stated that Gilead will be able to quadruple production of its cell therapy cancer treatments by 2026 due to improvements in the U.S. biotech’s manufacturing processes.

US FDA grants accelerated approval for Iovance’s skin cancer cell therapy Feb 16 (Reuters) – Iovance Biotherapeutics (IOVA.O) said on Friday the U.S. health regulator has granted an accelerated approval for its […]

The new facility in Rockville, Maryland will focus on manufacturing for critical cancer trials and launch of its commercial cell therapy platforms.

Cancer treatment maker 2seventy bio,  said it will sell all its experimental cell therapies to Regeneron Pharmaceuticals to focus on its only approved product Abecma.

How pharma companies can communicate effectively in today’s evolving marketplace and why it is the right time to embrace our humanity when engaging various stakeholders along the product, patient, and reimbursement/coverage journeys.

Get the updates on the latest news and industry developments from JPM24.

The agency is investigating reports of secondary blood cancers in patients who have received certain CAR T cell therapies, but experts say the risk is low and is outweighed by the terminal nature of some cancers.

The U.S. health regulator will not meet its Dec. 16 deadline on the use of Bristol Myers Squibb and partner 2seventy bio’s blood cancer therapy in earlier lines of treatment as it plans to seek the advice of independent experts before making a decision, the companies said.

A pair of new initiatives are infusing money into life sciences innovation in New York at a time when biotech funding is generally scarce. Together, the recently-announced projects, spearheaded by the state and the Chan Zuckerberg Initiative, will bring about $370 million in funding to biotech in the Empire State.

At a time when the volatility in the biopharma market is scaring investors—with layoffs and pipeline cuts abounding—a new report suggests that cell and gene therapies could be safer bets than other types of drugs.